Related Experiment Video

Updated: Jul 28, 2026

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

Removal of TSE agents from blood products

P R Foster1

  • 1Scottish National Blood Transfusion Service, Protein Fractionation Centre, Edinburgh, UK. peter.foster@snbts.csa.scot.nhsuk

Vox Sanguinis
|June 24, 2004
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

Related Experiment Videos

Last Updated: Jul 28, 2026

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Masking and Demasking Agents01:19

Masking and Demasking Agents

EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on the metal...

Articles linked to this work by shared authors, journal, and citation graph.

The precipitation of enzymes from cell extracts of Saccharomyces cerevisiae by polyethyleneglycol.

Biochimica et biophysica acta·2009

Effect of weight loss on inflammatory and endothelial markers and FMD using two low-fat diets.

International journal of obesity (2005)·2005

Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII.

Vox sanguinis·2004

Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin.

Vox sanguinis·2002

Prions and blood products.

Annals of medicine·2000

Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products.

Vox sanguinis·2000

Evaluating Australia's plasma pathway and rethinking transgender donor sexual activity restrictions: Zero donor detections of transfusion-transmissible infections in 6 months following changes to source plasma donation eligibility for sexual activity and HIV pre-exposure prophylaxis.

Vox sanguinis·2026

Motivational regulation for blood donation among Iranian blood donors: A nationwide mixed-effects study based on self-determination theory.

Vox sanguinis·2026

Eligibility of blood donors with thalassaemia trait, sickle cell trait or glucose-6-phosphate-dehydrogenase deficiency in Italy: Results of a national survey and practical guidance.

Vox sanguinis·2026

Impact of additive solutions on haematocrit measurement and red blood cell integrity: A comparative study of SAGM and PAGGSM.

Vox sanguinis·2026

Identification of a novel high-prevalence red blood cell antigen on junctional adhesion molecule-A defines a new blood group system.

Vox sanguinis·2026

Continuous agitation induces aggregate formation in cold-stored platelets during extended storage in platelet additive solution.

Vox sanguinis·2026

Occupational risk assessment of p-tert-butylphenol: toxicity reference values and worker exposure evaluation.

Toxicological research·2026

Public transparency and physicochemical standardization in the regulation of PMMA dermal fillers: a comparative analysis of FDA, EU MDR, and ANVISA frameworks.

Regulatory toxicology and pharmacology : RTP·2026

Balancing safety and efficiency in large-scale HRC: A dynamic scheduling method confronting temporal and spatial uncertainty of human workers.

iScience·2026

A Corner-Analysis-Based Method for Dimensional Inspection and Defect Detection of Glass Chamfers.

Sensors (Basel, Switzerland)·2026

Development of a User Requirement Specification (URS) for a Biofluorescent Particle Counter (BFPC) for Surface and Personnel Monitoring in Aseptic Processing Areas: Poster Presented at PDA Week 2026.

PDA journal of pharmaceutical science and technology·2026

Bridging the Gap: Mitigating a Hidden Cleaning Risk in Large-Scale Freeze-Thaw Unit Commissioning: Poster Presented at PDA Week 2026.

PDA journal of pharmaceutical science and technology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us